Dengue Classification
The current clinical classification of dengue follows the 2009 WHO system, which categorizes dengue into three groups: dengue without warning signs, dengue with warning signs, and severe dengue—this classification has largely replaced the older DF/DHF/DSS system due to superior sensitivity and clinical utility. 1
The 2009 WHO Classification System
The modern approach classifies dengue into three distinct categories 1:
1. Dengue Without Warning Signs
- Acute febrile illness with characteristic symptoms
- Frontal headache, retro-orbital pain, muscle and joint pain, and rash 2
- No indicators of plasma leakage or severe complications
2. Dengue With Warning Signs
The presence of any of the following warning signs indicates patients at risk for progression to severe disease 3:
- Abdominal pain or tenderness
- Persistent vomiting
- Clinical fluid accumulation (pleural effusion, ascites)
- Mucosal bleeding
- Lethargy or restlessness
- Liver enlargement >2 cm
- Increasing hematocrit concurrent with rapid decrease in platelet count
3. Severe Dengue
Defined by the presence of any of the following 1:
- Severe plasma leakage leading to shock or fluid accumulation with respiratory distress
- Severe bleeding requiring transfusion
- Severe organ involvement: liver (AST or ALT ≥1000 U/L), CNS (altered consciousness, encephalopathy), heart, or other organs
Comparison with the Traditional Classification
The older WHO classification (pre-2009) used dengue fever (DF), dengue hemorrhagic fever (DHF), and dengue shock syndrome (DSS) 4. This system had significant limitations:
- DHF/DSS showed only 39.0% sensitivity for capturing severe cases requiring intensive care 5
- The revised classification (severe dengue) demonstrated 92.1% sensitivity and 78.5% specificity for identifying cases needing heightened care 5
- The traditional system required all four criteria (hemorrhagic manifestations, thrombocytopenia ≤100,000/mm³, plasma leakage, fever), which proved difficult to apply consistently 6
Clinical Application Advantages
The 2009 classification offers several practical benefits:
- Dynamic disease monitoring: Captures the progressive nature of dengue, allowing clinicians to track patients as they move between categories 3
- Early risk identification: Warning signs help identify patients at risk of shock in both children and adults before decompensation occurs 3
- Treatment guidance: Facilitates appropriate triage and resource allocation during outbreaks 3
- Higher sensitivity: Reduces missed severe cases compared to the DHF/DSS criteria 5
Important Clinical Caveats
Cardiac involvement occurs in 12-50% of hospitalized dengue patients and includes arrhythmias, pericarditis, myocarditis, and myocardial dysfunction—these manifestations may be underdiagnosed, particularly in endemic areas 1. Men face higher risk of cardiac complications with increased rates of left ventricular systolic dysfunction 1.
Atypical presentations can occur, particularly in older adults (>65 years), who face increased risks of severe disease, extended hospitalizations, and higher mortality due to immune senescence and multimorbidity 7. Diagnosis in this population can be challenging due to non-specific symptoms.
Diagnostic timing matters: PCR is positive early in illness, while IgM capture ELISA becomes positive after 5-7 days of symptoms 4. Cross-reactivity with other flaviviruses (yellow fever, Japanese encephalitis, tick-borne encephalitis) can complicate serologic interpretation 4.
The 2009 classification has been validated across multiple endemic regions and age groups, demonstrating superior performance for clinical management, research applications, and epidemiological surveillance compared to the traditional system 3, 5.